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Abstract
Background: The 28-joint Disease Activity Score (DAS28) combines scores on a 28-tender and swollen joint count (TJC28
and SJC28), a patient-reported measure for general health (GH), and an inflammatory marker (either the erythrocyte
sedimentation rate [ESR] or the C-reactive protein [CRP]) into a composite measure of disease activity in rheumatoid arthritis
(RA). This study examined the reliability of the DAS28 in patients with early RA using principles from generalizability theory
and evaluated whether it could be increased by adjusting individual DAS28 component weights.
Methods: Patients were drawn from the DREAM registry and classified into a ‘‘fast response’’ group (N = 466) and ‘‘slow
response’’ group (N = 80), depending on their pace of reaching remission. Composite reliabilities of the DAS28-ESR and
DAS28-CRP were determined with the individual components’ reliability, weights, variances, error variances, correlations
and covariances. Weight optimization was performed by minimizing the error variance of the index.
Results: Composite reliabilities of 0.85 and 0.86 were found for the DAS28-ESR and DAS28-CRP, respectively, and were
approximately equal across patients groups. Component reliabilities, however, varied widely both within and between sub-
groups, ranging from 0.614 for GH (‘‘slow response’’ group) to 0.912 for ESR (‘‘fast response’’ group). Weight optimization
increased composite reliability even further. In the total and ‘‘fast response’’ groups, this was achieved mostly by decreasing
the weight of the TJC28 and GH. In the ‘‘slow response’’ group, though, the weights of the TJC28 and SJC28 were increased,
while those of the inflammatory markers and GH were substantially decreased.
Conclusions: The DAS28-ESR and the DAS28-CRP are reliable instruments for assessing disease activity in early RA and
reliability can be increased even further by adjusting component weights. Given the low reliability and weightings of the
general health component across subgroups it is recommended to explore alternative patient-reported outcome measures
for inclusion in the DAS28.
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Introduction
If a concept or condition is too complex to measure with a single
instrument, multiple measurements are often combined into a
linear composite score (i.e. an index measure). For rheumatoid
arthritis (RA) the 28-joint Disease Activity Score (DAS28) is such
an index measure, widely used for determining a patient’s degree
of disease activity [1]. It consists of 4 different individual
components: a 28-tender joint count, a 28-swollen joint count, a
patient-reported rating of general health, and a non-specific acute
phase reactant of systemic inflammation which can be either the
erythrocyte sedimentation rate (ESR) or the C-reactive protein
(CRP). Each component has its own specific weight in the
composite score, based on canonical discriminant functions for
classifying high and low disease activity.
The DAS28 has received much attention over the years and has
been shown to be a valid measure [1,2]. However, since reliability
is a prerequisite for validity [3], the index should be reliable as
well. While several studies have already determined the reliability
of the DAS28 using Cronbach’s Alpha [2,4,5], it is not appropriate
to use this internal consistency measure with an index measure, as
opposed to scales. Where a scale consists of correlated items which
all measure the same construct, an index consists of items which
are not necessarily highly correlated but which are considered
indicators because they themselves define the construct [6]. As a
result, the components might measure completely different aspects
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of disease activity, which is also the case with the DAS28. This
poses significant methodological challenges for reliability testing.
To overcome these challenges, generalizability theory [7,8] can be
used to estimate the reliability of an index score by disentangling
different sources of error.
As such, the first aim of this study was to determine the
reliability of the DAS28 using generalizability theory. Since
reliability is a concept defined relative to a specific population of
patients [9], the second aim of this study was to examine whether
the reliability of the index is acceptably high in relevant
subpopulations and whether this reliability can be increased by
adjusting the weightings of the individual component scores within
the DAS28, which was shown to be the case.
Methods
Ethics Statement
As evaluated by the ethics committees of the participating
hospitals, and in accordance with Dutch law, no ethical approval
was required because data collection took place in daily clinical
practice. Nevertheless, informed consent was obtained from each
patient.
Patients
Patients were drawn from the remission induction cohort of the
Dutch Rheumatoid Arthritis Monitoring (DREAM) registry [10].
This observational multicenter cohort started in 2006 and,
although patient recruitment for this cohort has stopped in
2012, data collection of included patients is still ongoing. For this
study, all data available at 0, 3, 6, 9, and 12 months were
accessible for analyses. To be eligible for inclusion in the cohort,
patients were DMARD and prednisolone naı¨ve, they were allowed
to have a maximum symptom duration of 1 year, and they needed
to be 18 years or older. Additionally, they were not in remission, as
measured with the DAS28. Early RA classification was based on a
clinical diagnosis by the rheumatologist. For the present study,
patients were classified into 2 groups as identified in the study by
Siemons et al. [11]: a ‘‘fast response’’ group of patients quickly
reaching remission and a ‘‘slow response’’ group of patients
reaching remission at a slower pace. Because reliability calcula-
tions are sample dependent slight differences can be expected
between the two response groups.
Measures
The primary measures of interest were the 28-tender joint count
(TJC28), the 28-swollen joint count (SJC28), a 100 millimeter
visual analogue scale on general health (GH: where 0 = very good
and 100 = very bad), the erythrocyte sedimentation rate (ESR),
and the C-reactive protein (CRP). Using these variables, the
DAS28-ESR and DAS28-CRP were calculated as follows [12]:
DAS28{ESR~0:56 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TJC28
p
z0:28 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SJC28
p
z
0:70  Ln(ESR)z0:014  GH
ð1Þ
DAS28{CRP~0:56 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TJC28
p
z0:28 
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SJC28
p
z
0:36  Ln(CRPz1)z0:014  GHz0:96
ð2Þ
Patients additionally completed the Health Assessment Ques-
tionnaire (HAQ) which measures physical functioning [13] and the
36-item Short Form Health Survey (SF-36) which assesses physical
and mental health status [14].
Statistical analyses
Baseline between-group comparisons were made using inde-
pendent t-tests for normally distributed continuous variables,
Kruskal Wallis tests for variables with skewed distributions, and
Chi-Square tests for dichotomous variables.
Although a DAS28 score is assumed to represent a patient’s
disease activity, in reality this score consists of two parts: 1) the
actual (true) score of that patient’s disease activity, and 2) random
measurement errors [3]. Errors give rise to an under- or
overestimation of the true score. This might be due to, among
others, certain distractions during test administration, the patient’s
mood while filling out the test, or a misreading of the items.
Reliability is a representation of measurement consistency; it is the
ratio between true score variance and observed total score
variance, where the latter consists of a true score part and an
error part [3]. Higher error variance leads to lower reliability.
However, although these basic principles do apply to the
individual components of the DAS28, the composite reliability
of an index also depends on the interrelationships of its
components. Composite reliability is a function of the reliability
of the individual components, the weights that are assigned to the
components as reflected in the DAS28 formulas, the variances and
error variances of the component scores, and the correlations and
covariances between the different components. All this can be
combined into the following formula [8,15]:
r~1{
Pn
i~1
(w2i s
2
e,Xi)
Pn
i~1
(w2i s
2
Xi)z
Pn
i~1
Pn
j(=i)~1
(wiwjsXi,Xj)
ð3Þ
Where:
I. wiis the weight of component i, as defined in the DAS28
formulas 1 and 2 described above;
II. s2Xi is the observed variance of component i;
III. s2e,Xi is the error variance of component i, which is a
function of the component reliability and the observed
variance: s2e,Xi = (1 - reliability of component i) * s
2
Xi;
IV. sXi,Xj is the covariance between the two components,
which can be rewritten as: Correlation Xi,Xj* Standard deviation
Xi* Standard deviation Xj .
Note that the nominator of the ratio in formula 3 is the error
variance of the index, while the denominator is the total variance.
In this study, the error variances of joint count components
were calculated from their observed variance and reliability levels,
whereas the error variances of GH and both inflammatory
measures were obtained from univariate linear regression analyses.
However, two significant problems arose during component
reliability computations.
First, it was not appropriate to calculate the reliabilities of the
joint count components with Cronbach’s Alpha, since Cronbach’s
Alpha assumes the total score to be a linear combination of all
items (i.e. each item is regarded as a parallel test of the other
component items) whereas the joint count components are square
root transformed in the DAS28. Consequently, split-half reliabil-
ities were determined instead. As demonstrated by Siemons et al.
[16], RA is characterized by a definite left-right symmetry of joint
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involvement. Consequently, the square root sum scores of the left
and right joints were considered to represent two parallel tests and
their correlation was used as an estimate of reliability.
Second, given the structure of the cohort, with time frames of
several weeks or even months between consecutive measurements,
it was not possible to perform proper test-retest reliabilities for the
single-item components (i.e. ESR, CRP, and GH). Therefore, a
generalizability theory principle was used to determine reliability.
After running a univariate general linear model analysis on a
longitudinal dataset (including all available data at 0, 3, 6, 9, and
12 months) the person variance could be separated from the time
variance and reliability could be calculated as the ratio between
person variance and total variance.
All computations of reliabilities were performed on the total
patient group as well as on the two identified subgroups using
SPSS version 21.0.
After calculating the composite reliabilities, it was investigated
whether the reliability in both the total as well as the specific
patient groups could be optimized by adjusting the component’s
weights. Optimal weights were computed by minimizing the error
variance of the index, that is, the nominator of the ratio in formula
3, subject to the constraint that the total variance of the index does
not change. The resulting quadratic optimization problem under
quadratic constraints was solved using a procedure developed by
Albers, Critchley, and Gower [17]. For more applications, refer to
Albers, Critchley, and Gower [18].
Results
Patients
A total of 565 patients were included for analysis; 466 from the
‘‘fast response’’ group and 80 from the ‘‘slow response’’ group.
Overall, they had a mean age of approximately 58 years, the
majority were women (63%) and rheumatoid factor positive (54%),
and their baseline disease was characterized by several tender and
swollen joints as well as by a diminished physical health status
(Table 1).
No significant differences were found in age, mental health, or
rheumatoid factor positivity between the fast and slow response
group, but the slow response group did contain significantly more
women. Additionally, the slow response group had a significantly
worse disease condition, characterized by higher DAS28 scores, a
poorer state of general and physical health, higher levels of
inflammatory markers, and a higher number of tender and swollen
joints, as compared to the fast response group.
Reliability calculations
Tables 2–4 show the variances, error variances and reliabilities
of the individual components together with their correlations and
covariances. All correlations were small to moderate, as is not
unusual in index measures. Component reliabilities varied widely
both within and between sub-groups, ranging from 0.614 for GH
in the ‘‘slow response’’ group to 0.912 for ESR in the ‘‘fast
response’’ group. Furthermore, ESR component reliabilities were
highest and the TJC28 outperformed the SJC28 across all groups.
Using formula 3 resulted in overall reliabilities of 0.85 and 0.86
for the DAS28-ESR and DAS28-CRP composites, respectively.
Sub-analyses showed DAS28-ESR reliabilities of 0.85 and 0.82
and DAS28-CRP reliabilities of 0.85 and 0.84 for the ‘‘fast
response’’ and ‘‘slow response’’ group, respectively. These results
demonstrate that both DAS28 scores are approximately equally
reliable across patient groups, that is, the differences were only
small and all reliability levels were high (.0.80).
Optimizing reliability
The results of the optimization of composite reliability by
adjusting the weights are shown in Table 5. The original weights
are given in the third column. The next three columns give the
estimated optimal weights in the total group and in the ‘‘fast
response’’ and ‘‘slow response’’ groups, respectively. Further, in
Table 1. Patient characteristics and group comparisons at inclusion.
Variable
Mean (SD) or Median
(range)* Total group
Mean (SD) or Median (range)*
‘‘Fast response’’ group
Mean (SD) or Median (range)*
‘‘Slow response’’ group
Significance (p) group
comparisons
Gender (female) 342/546 (62.6%) 283/466 (60.7%) 59/80 (73.8%) 0.026,
Age (years) 57.96 (14.31) 57.85 (14.62) 58.59 (12.41) 0.672"
DAS28-ESR 4.28 (1.45) 4.11 (1.42) 5.22 (1.29) ,0.001"
DAS28-CRP 4.02 (1.31) 3.88 (1.28) 4.79 (1.24) ,0.001"
28-Tender joint count 3 (0–28) 3 (0–28) 6 (0–28) ,0.001#
28-Swollen joint count 5 (0–24) 4 (0–24) 6.50 (0–24) 0.001#
GH 44.32 (26.11) 42.52 (25.76) 54.82 (25.83) ,0.001"
ESR (mm/hour) 21.50 (1–120) 20 (1–111) 30 (7–120) ,0.001#
CRP (mg/l) 9.00 (1–158) 6 (1–158) 11 (1–115) 0.004#
Rheumatoid factor + 274/506 (54.2%) 233/431 (54.1%) 41/75 (54.7%) 0.923,
SF36 – physical health 37.17 (9.09) 37.93 (9.09) 32.91 (7.88) 0.001"
SF36 – mental health 48.16 (11.67) 48.55 (11.37) 45.99 (13.07) 0.094"
HAQ 1.00 (0.72) 0.92 (0.70) 1.41 (0.66) 0.001"
*The values for gender and rheumatoid factor positivity are the number of patients/number of patients assessed (%).
#Group comparisons performed with Kruskall Wallis tests.
,Group comparisons performed with Chi-Square tests.
"Group comparisons performed with independent t-tests.
DAS28 = disease activity score for 28 joints, GH = general health, ESR = erythrocyte sedimentation rate, CRP = C-Reactive Protein, SF36 = Short Form Health Survey
with 36 items, HAQ = Health Assessment Questionnaire.
doi:10.1371/journal.pone.0100544.t001
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the rows labeled ‘‘Reliability’’, the reliabilities using the original
weights and the optimal weights are given.
In all groups, reliabilities increased after weight optimization.
The largest gains were obtained in the total and ‘‘fast response’’
groups by decreasing the weight of the TJC and GH. In the
smaller slow response group, on the other hand, the weights of the
TJC28 and SJC28 were increased, while the weights of the
inflammatory markers and GH were substantially decreased.
Discussion
Overall, composite reliability levels of 0.85 and 0.86 were found
for the DAS28-ESR and DAS28-CRP, respectively. This is
sufficiently high for group use and around common thresholds
considered sufficient for individual use [19,20], justifying the use of
the DAS28 in both clinical research and clinical practice.
Moreover, reliability could be increased even further by optimiz-
ing the component weights.
Table 2. Variances, error variances and reliabilities of the DAS-28 components.
Total patient group (N=546) ‘‘Fast response’’ group (N=466) ‘‘Slow response’’ group (N=80)
Component Variance
Error
variance
Component
Reliability Variance
Error
variance
Component
Reliability Variance
Error
variance
Component
Reliability
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TJC28
p
1.756 0.400 0.772 1.580 0.409 0.741 2.085 0.325 0.844
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SJC28
p
1.521 0.420 0.724 1.522 0.425 0.721 1.342 0.394 0.706
GH 681.624 269.687 0.783 663.439 247.769 0.766 666.917 359.309 0.614
LN(ESR) 0.779 0.193 0.913 0.807 0.191 0.912 0.477 0.191 0.878
LN(CRP) 0.909 0.246 0.805 0.920 0.231 0.806 0.771 0.335 0.773
TJC28 = 28-tender joint count, SJC28 = 28-swollen joint count, GH = general health, ESR = erythrocyte sedimentation rate,
CRP = C-Reactive Protein.
doi:10.1371/journal.pone.0100544.t002
Table 3. Pearson’s correlations and covariances of DAS-28 components in total patient sample.
Covariance
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TJC28
p ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SJC28
p
GH LN(ESR) LN(CRP)
Pearson’s Correlation
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TJC28
p
---- 0.909 14.818 0.152 0.207
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SJC28
p
0.555** ---- 8.467 0.337 0.402
GH 0.427** 0.262** ---- 4.129 5.181
LN(ESR) 0.131** 0.309** 0.179** ---- 0.488
LN(CRP) 0.164** 0.343** 0.207** 0.581** ----
**p,0.01, TJC28 = 28-tender joint count, SJC28 = 28-swollen joint count, GH = general health, ESR = erythrocyte sedimentation rate, CRP = C-Reactive Protein.
doi:10.1371/journal.pone.0100544.t003
Table 4. Pearson’s correlations of the DAS-28 components in the ‘‘fast response’’ group and ‘‘slow response’’ group.
Pearson’s
correlation group
2 (N=80)
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TJC28
p ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SJC28
p
GH LN(ESR) LN(CRP)
Pearson’s
correlation
group 1
(N=466)
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TJC28
p
1 0.547** 0.313** 20.09 20.032
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SJC28
p
0.545** 1 0.288* 0.143 0.263*
GH 0.423** 0.239** 1 0.067 0.104
LN(ESR) 0.125** 0.312** 0.166** 1 0.578**
LN(CRP) 0.171** 0.342** 0.205** 0.574** 1
**p,0.01, TJC28 = 28-tender joint count, SJC28 = 28-swollen joint count, GH = general health, ESR = erythrocyte sedimentation rate, CRP = C-Reactive Protein.
doi:10.1371/journal.pone.0100544.t004
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Several findings are worth mentioning when comparing the
individual component reliabilities or when optimizing the compo-
nent weights. At first, it can be observed that ESR had the highest
reliability of all DAS28 components. The finding that this measure
of inflammation was also more reliable than the CRP measure
might be explained by their different responsiveness to changes in
inflammatory stimuli. While the ESR is a relatively stable measure
over time, which responds slowly to changes and reflects the
disease activity of the past few weeks, the CRP fluctuates more
heavily due to a more rapid response to short-term changes in the
inflammatory stimuli [12,21,22]. The ESR is also given a higher
weighting than the CRP in the DAS28 formulas and that
remained to be the case after weight optimization.
When looking at the joint count reliabilities, the swollen joint
count had a lower reliability than the tender joint count, consistent
with findings from previous studies [9,23,24]. Joint counts are
sometimes referred to as a semi-objective clinical measures [1]
and, as discussed by Pincus [25], they have been shown to be
poorly reproducible. Large intra- and interobserver variability is
commonly found especially in the swollen joint count [24]. This
might be explained by a higher dependency of the swollen joint
assessment on factors like the assessors’ levels of training and
experience, a lack of standardization in examination methods,
unclear definitions of swelling, or the degree of joint deformity
[24,25,26]. After weight optimization, however, the weight of the
tender joint count was substantially lowered, even below the
weight of the swollen joint count. This corresponds with the
common clinical perspective of disease activity in RA. Joint
swelling is usually considered to be a more representative measure
of inflammation than joint tenderness [27] and has been shown to
play a major role in the physician’s assessment of disease activity
[28].
Finally, it can be observed that the patient reported degree of
GH in the ‘‘slow response’’ group had the lowest reliability of all
components, even below the recommended reliability threshold
for group use (r.0.70). Its weight was also substantially decreased
after weight optimization. This could be a confirmation of the
weakness of this component, as the inclusion of GH in the DAS28
has been often criticized. For instance, previous studies have
shown elevated GH scores while none of the other DAS28
components showed any sign of an active disease, possibly due to
effects beyond the clinical inflammatory processes of RA [29].
Also, GH ratings have been shown to be different across patients
with similar DAS28 scores, dependent on the moment of
administration, possibly caused by a response shift [30]. The
GH component is also the most subjective component of the
DAS28 and, therefore, more susceptible to measurement error.
Although it could be argued to solely include the more objective
clinical measures, the inclusion of a patient-driven component is
desirable given the increased awareness of the importance of the
patient perspective in assessing disease activity since the 1980s [31]
as reflected by their inclusion in the provisional ACR/EULAR
definition of remission in RA [32] as well as in the preliminary
core set of disease activity measures [33]. Disease activity in RA is
a multifactorial concept and appears to be best measured by both
objective clinical measures and patient-reported outcomes as they
each address a different aspect of disease activity [27]. Therefore,
it would be interesting to explore other, more reliable, patient-
reported outcome measures for inclusion in the DAS28. What
measure would be best warrants further research. Measures of
pain or fatigue appear to be promising alternatives, given the
recognition of pain as one of the most important determinants of a
patient’s global assessment of disease activity [34,35,36] and the
recommendation to measure fatigue in addition to the other core
set measures of RA [37]. But, of course, other patient-reported
measures can also be explored.
A possible limitation of the current study is the difference in
sample size between the fast response and slow response group.
Though this might cause the results of the ‘‘fast response’’ group to
be more robust than the results of the ‘‘slow response’’ group, the
importance of the tender joint count in the slow response group is
consistent with the general belief that approximately 10-20% of
Table 5. Reliabilities of the index measures and optimal weights in subpopulations.
Index measure Component * Original Weight
Total patient group
(N=546)
‘‘Fast response’’ group
(N=466)
‘‘Slow response’’
group (N=80)
DAS28-ESR
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TJC28
p
0.560 (0.742) 0.226 (0.299) 0.156 (0.196) 0.739 (1.067)
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SJC28
p
0.280 (0.345) 0.271 (0.334) 0.226 (0.279) 0.355 (0.411)
GH 0.014 (0.366) 0.004 (0.104) 0.004 (0.103) 0.004 (0.103)
LN(ESR) 0.700 (0.618) 0.663 (0.585) 0.650 (0.584) 0.052 (0.036)
Reliability Original
Weights
0.854 0.848 0.821
Optimal
Weights
0.933 0.942 0.859
DAS28-CRP
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
TJC28
p
0.560 (0.742) 0.374 (0.496) 0.247 (0.310) 0.720 (1.040)
ffiffiffiffiffiffiffiffiffiffiffiffiffiffi
SJC28
p
0.280 (0.345) 0.378 (0.466) 0.298 (0.368) 0.356 (0.412)
GH 0.014 (0.366) 0.006 (0.157) 0.005 (0.129) 0.004 (0.103)
LN(CRP) 0.360 (0.343) 0.522 (0.498) 0.571 (0.548) 0.028 (0.025)
Reliability Original
Weights
0.858 0.852 0.845
Optimal
Weights
0.888 0.911 0.858
The weights between brackets are the standardized values by fixing the component variances at 1.
*TJC28 = 28-tender joint count, SJC28 = 28-swollen joint count, GH = general health, ESR = erythrocyte sedimentation rate, CRP = C-Reactive Protein.
doi:10.1371/journal.pone.0100544.t005
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patients with RA have secondary fibromyalgia (FM) [38,39]. FM
patients tend to have a lower pain threshold [38,39] which might
explain the higher relevance of the TJC28 rating in this patient
group, increasing our confidence in the robustness of the results.
Conclusions
The DAS28-ESR and the DAS28-CRP are both reliable
instruments for assessing disease activity in early RA although
reliability can be increased even further by adjusting the individual
component weights. Overall, the findings suggest that the largest
gains in reliability can be achieved by substantially lowering the
weights of the tender joint count and patient-reported general
health. Future studies should explore the possibilities of including a
better indicator of the patient perspective in the disease activity
score.
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